Market
How will NVIDIA's revenue be impacted by the Chinese antitrust investigation by end of fiscal year 2025?
2
Resolution / Starting Odds
Decrease over 5% • 25%
Decrease 1-5% • 25%
No significant change • 25%
Increase • 25%
NVIDIA's financial reports and earnings calls
Story
NVIDIA Shares Drop as China Launches Antitrust Probe Over Alleged Anti-Monopoly Violations
Dec 9, 2024, 12:01 PM
On December 9, 2024, China's State Administration for Market Regulation (SAMR) announced an antitrust investigation into U.S. chipmaker NVIDIA over alleged violations of China's Anti-Monopoly Law. The probe focuses on suspicions that NVIDIA has breached anti-monopoly regulations, including potential non-compliance with restrictive conditions from the 2020 antitrust review of its acquisition of Mellanox Technologies. The investigation was reported by Chinese state media, including CCTV. NVIDIA's shares dropped over 2% in pre-market trading following the news. China accounts for approximately 15% of NVIDIA's data center revenue, implying about $4.5 billion in the third quarter and around 13% of its total revenue for the period.
View original story
Similar markets
Increase by over 10% • 25%
Decrease by over 20% • 25%
Decrease by 10-20% • 25%
Change within +/-10% • 25%
Increases • 25%
Decreases by less than 10% • 25%
Remains stable • 25%
Decreases by 10% or more • 25%
No significant change • 25%
Increase in revenue • 25%
Decrease up to 10% • 25%
Decrease more than 10% • 25%
Loss of market share • 25%
Increased market position • 25%
No significant impact • 25%
Revenue decline • 25%
Other regulatory actions • 25%
Nvidia required to divest assets • 25%
No action taken • 25%
Nvidia fined • 25%
Fines imposed • 25%
Deal reversal • 25%
No action taken • 25%
Operational restrictions • 25%
No significant change • 25%
Increase in revenue • 25%
Decrease in revenue • 25%
Severe revenue impact • 25%
Acquisition reversal • 25%
No action taken • 25%
Operational restrictions • 25%
Fines imposed • 25%
Other outcome • 25%
Fine imposed • 25%
No action taken • 25%
Operational restrictions • 25%
Compliance with demands • 25%
Withdrawal from Chinese market • 25%
Legal challenge • 25%
Other response • 25%